ENvue Medical, Inc. (FEED) Form 8-K — Oct 14, 2026
ENvue Medical (FEED) entered a secured promissory note with Alpha Capital Anstalt on October 8, 2026 for up to $1,000,000, with a $250,000 initial tranche funded the same day. The note bears 10% interest (18% upon default), matures December 31, 2026, and is secured by a blanket security interest in substantially all company assets, including patents, inventory, and equity of its subsidiaries. The lender can unilaterally extend the maturity in three-month increments through December 31, 2028, and the company must repay $10,000 of lender fees. The blanket lien over all assets including core IP signals significant balance-sheet stress for the micro-cap medical device maker.
Key figures
- Debt Amount
- $1,000,000 (up to), $250,000 initial tranche funded
- Interest Rate
- 10
- Maturity Date
- 2026-12-31
- Extension right
- Lender may extend maturity in 3-month increments through Dec 31, 2028
- Default interest rate
- 18% (or highest lawful rate)
- Amendment holder approval
- 70% of outstanding Series X Preferred
- Series x conversion price
- $0.50
- Series x authorized shares
- 57720
- Lender expense reimbursement
- $10,000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.